Your browser doesn't support javascript.
loading
The most severe form of LMNA-associated congenital muscular dystrophy.
Murofushi, Yuka; Hayakawa, Itaru; Abe, Yuichi; Nakao, Hiro; Ono, Hiroshi; Kubota, Masaya.
Afiliación
  • Murofushi Y; Division of Neurology, National Center for Child Health and Development (NCCHD), 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan. Electronic address: murofushi-y@ncchd.go.jp.
  • Hayakawa I; Division of Neurology, National Center for Child Health and Development (NCCHD), 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
  • Abe Y; Division of Neurology, National Center for Child Health and Development (NCCHD), 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
  • Nakao H; Department of General Pediatrics and Interdisciplinary Medicine, NCCHD, Tokyo, Japan.
  • Ono H; Division of Cardiology, NCCHD, Tokyo, Japan.
  • Kubota M; Division of Neurology, National Center for Child Health and Development (NCCHD), 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan; Department of Pediatrics, Shimada Ryoiku Medical Center for Challenged Children, 1-31-1 Nakazawa, Tama City, Tokyo 206-0036, Japan.
Brain Dev ; 44(9): 650-654, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35729056
Alterations in the LMNA gene cause a wide spectrum of diseases collectively called laminopathies. LMNA-associated congenital muscular dystrophy is a form of laminopathy, which usually causes infantile onset of muscle weakness, predominantly in the cervical-axial muscles, and motor developmental retardation. Cardiac symptoms during the first decade of life are rare. We report a case of LMNA-associated congenital muscular dystrophy in which the patient did not achieve head control and experienced facial muscle weakness. Cardiac dysrhythmias were observed at 5 years with development of dilated cardiomyopathy and ischemic strokes at 7 years. Despite intensive medical intervention, he died suddenly at 9 years. This report broadens the spectrum of phenotypes of this disorder with the most severe symptoms during the first decade of life. Our case underscores the need for early genetic testing for LMNA in patients with congenital muscular dystrophy to screen for cardiac manifestations and intervene as necessary.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lamina Tipo A / Distrofias Musculares Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Brain Dev Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lamina Tipo A / Distrofias Musculares Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Brain Dev Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos